- Filed
- Feb 17, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Feb 17, 2026 | 79.89M sh |
| Shares Diluted | Q1 2026 · Oct 31, 2025 | 73.89M sh |
| Shares Diluted | Q1 2026 · Oct 31, 2024 | 45.42M sh |
| Operating Cash Flow | Q1 2026 · Oct 31, 2025 | −$218.48K |
| Operating Cash Flow | Q1 2026 · Oct 31, 2024 | −$4.58K |
| Stockholders Equity | Q1 2026 · Oct 31, 2025 | −$4M |
| Stockholders Equity | Q1 2026 · Jul 31, 2025 | $624.46K |
| Stockholders Equity restated | Q1 2026 · Oct 31, 2024 | −$257.81K |
| Stockholders Equity | Q1 2026 · Jul 31, 2024 | −$182.11K |
| Current Liabilities | Q1 2026 · Oct 31, 2025 | $3.46M |
| Current Liabilities | Q1 2026 · Jul 31, 2025 | $155.36K |
| Total Liabilities | Q1 2026 · Oct 31, 2025 | $4.12M |
| Total Liabilities | Q1 2026 · Jul 31, 2025 | $179.06K |
| Current Assets | Q1 2026 · Oct 31, 2025 | $55.46K |
| Current Assets | Q1 2026 · Jul 31, 2025 | $95.42K |
| Total Assets | Q1 2026 · Oct 31, 2025 | $113.58K |
| Total Assets | Q1 2026 · Jul 31, 2025 | $803.52K |
| Eps Diluted | Q1 2026 · Oct 31, 2025 | −$2.08 |
| Eps Diluted | Q1 2026 · Oct 31, 2024 | $0.00 |
| Sga Expense | Q1 2026 · Oct 31, 2025 | $182.82K |
| Sga Expense | Q1 2026 · Oct 31, 2024 | $114.08K |
| Rd Expense | Q1 2026 · Oct 31, 2025 | $153.4M |
| Rd Expense | Q1 2026 · Oct 31, 2024 | $0 |
| Net Income | Q1 2026 · Oct 31, 2025 | −$153.66M |
| Net Income restated | Q1 2026 · Oct 31, 2024 | −$91.06K |
| Operating Income | Q1 2026 · Oct 31, 2025 | −$153.62M |
| Operating Income restated | Q1 2026 · Oct 31, 2024 | −$89.14K |
| Gross Profit | Q1 2026 · Oct 31, 2025 | $0 |
| Gross Profit | Q1 2026 · Oct 31, 2024 | $25.08K |
| Cost Of Revenue | Q1 2026 · Oct 31, 2025 | $0 |
| Cost Of Revenue restated | Q1 2026 · Oct 31, 2024 | $18.49K |
| Revenue | Q1 2026 · Oct 31, 2025 | $0 |
| Revenue | Q1 2026 · Oct 31, 2024 | $43.57K |